Research programme: heat-shock factor 1 pathway inhibitors - The Institute of Cancer Research
Latest Information Update: 28 Jun 2020
At a glance
- Originator The Institute of Cancer Research
- Class Small molecules
- Mechanism of Action Heat-shock protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jun 2020 No recent reports of development identified for research development in Cancer in United Kingdom
- 05 May 2016 Early research in Cancer in United Kingdom (unspecified route)